Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Chem and Bio Engineering is Scopus-indexed (Q2, CiteScore 5.9), WoS ESCI, DOAJ. Published by American Chemical Society.
Checked against the index lists dated .
ISSN 2836-967XVerify ISSN ↗
Publisher: American Chemical Society
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Chemical Engineering (all) | 89 / 270 | 67th | Q2 |
| Biomedical Engineering | 132 / 342 | 61st | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2024–present, best quartile Q2, CiteScore 5.9.
Chem and Bio Engineering is Q2 in Chemical Engineering (all) (rank 89 of 270) and Q2 in Biomedical Engineering (rank 132 of 342), by CiteScore 2025.
Chem and Bio Engineering is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.9, which places it in quartile Q2 at the 67th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.734, quartile Q1, with an H-index of 13.
No article processing charge is recorded for it (source: OpenAlex). Confirm on the journal's own website, since some journals charge for extras such as colour figures.
Chem and Bio Engineering is published by American Chemical Society. Its ISSN is 2836-967X.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Chem and Bio Engineering has an h-index of 25 and a 2-year mean of 7.97 citations per paper (OpenAlex). Its Scopus CiteScore is 5.9, quartile Q2. On 2-year citations it ranks #16 of 246 Scopus journals in Chemical Engineering (all).
Chem and Bio Engineering published 97 papers in 2025; its busiest recent year was 2024 with 118. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from China (50.5%), United States (10.9%) and South Korea (5.7%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.